Expertise in
53
conditions

Dr. Ashit Jain

Internal Medicine
2333 Mowry Ave Ste 300, 
Fremont, CA 
Accepting New Patients
Offers Telehealth
Before you request
Expertise in
53
conditions
2333 Mowry Ave Ste 300, 
Fremont, CA 

Overview

Ashit Jain is a primary care provider, practicing in Internal Medicine in Fremont, California.

Dr. Jain is highly rated in 53 conditions, according to our data. His clinical expertise encompasses Necrosis, Heart Attack, Heart Failure with Preserved Ejection Fraction (HFpEF), Endoscopy, and Pacemaker Implantation.

He is actively involved in clinical research, co-authoring 2 peer reviewed articles and participating in 8 clinical trials. Dr. Jain is currently accepting new patients.

Specialties

Internal Medicine

Licenses

Internal Medicine in CA

Hospital Affiliations

St Rose Hospital
Washington Hospital
Stanford Health Care

Languages Spoken

English
Hindi

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Alignment Health Plan
  • MEDICARE MAPD
  • MEDICARE SNP
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Cambia Health Solutions
  • EPO
  • INSURANCE PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • PPO
Capital Blue Cross
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER MEDICARE PART D
  • PPO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Chinese Community Health
  • HMO
  • MEDICARE SNP
  • OTHER MEDICARE PART D
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Clover Health
  • INSURANCE PLAN
  • MEDICARE MAPD
Contra Costa Health
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • OTHER COMMERCIAL
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Health Net

Accepted plan types not found. Please verify directly with the provider.

Health Plan of San Mateo
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Kaiser Permanente
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER MEDICARE
  • POS
  • PPO
LA Care
  • HMO
  • MANAGED MEDICAID PLAN
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
Santa Clara Family Health Plan
  • MANAGED MEDICAID PLAN
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
SCAN Health Plan
  • INSURANCE PLAN
  • MEDICARE MAPD
Sutter Health
  • HMO
  • OTHER COMMERCIAL
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Valley Health
  • HMO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 24 Less Insurance Carriers -

Locations

California Cardiovascular Consultants Medical Associates
2333 Mowry Ave Ste 300, Fremont, CA 94538

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

8 Clinical Trials

A Double-Blind, Placebo-Controlled Phase 2b Study to Evaluate the Efficacy and Safety of ARO-APOC3 in Adults With Severe Hypertriglyceridemia
A Double-Blind, Placebo-Controlled Phase 2b Study to Evaluate the Efficacy and Safety of ARO-APOC3 in Adults With Severe Hypertriglyceridemia
Enrollment Status: Completed
Publish Date: March 24, 2026
Intervention Type: Drug
Study Drug: ARO-APOC3
Study Phase: Phase 2
LIFE-BTK (pivotaL Investigation of saFety and Efficacy of BRS Treatment-Below The Knee) Randomized Controlled Trial
LIFE-BTK (pivotaL Investigation of saFety and Efficacy of BRS Treatment-Below The Knee) Randomized Controlled Trial
Enrollment Status: Active_not_recruiting
Publish Date: December 30, 2025
Intervention Type: Device
Study Phase: Not Applicable
Carotid Revascularization and Medical Management for Asymptomatic Carotid Stenosis Trial
Carotid Revascularization and Medical Management for Asymptomatic Carotid Stenosis Trial
Enrollment Status: Completed
Publish Date: October 01, 2025
Intervention Type: Device, Other, Procedure
Study Phase: Not Applicable
Randomized & Controlled Noninferiority Trial to Evaluate Safety & Clinical Efficacy of SurVeil™ Drug-Coated Balloon (DCB) iN Treatment of Subjects With Stenotic Lesions of Femoropopliteal Artery Compared to Medtronic IN.PACT® Admiral® DCB
Randomized & Controlled Noninferiority Trial to Evaluate Safety & Clinical Efficacy of SurVeil™ Drug-Coated Balloon (DCB) iN Treatment of Subjects With Stenotic Lesions of Femoropopliteal Artery Compared to Medtronic IN.PACT® Admiral® DCB
Enrollment Status: Completed
Publish Date: March 25, 2025
Intervention Type: Device
Study Phase: Not Applicable
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Enrollment Status: Completed
Publish Date: October 30, 2023
Intervention Type: Device
Study Phase: Not Applicable
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Enrollment Status: Completed
Publish Date: October 11, 2023
Intervention Type: Device
Study Phase: Not Applicable
The OPTIMIZE Trial to Assess the Procedural and Clinical Value of the Svelte IDS and RX Sirolimus Eluting Coronary Stent Systems for the Treatment of Atherosclerotic Lesions in a Randomized Study
The OPTIMIZE Trial to Assess the Procedural and Clinical Value of the Svelte IDS and RX Sirolimus Eluting Coronary Stent Systems for the Treatment of Atherosclerotic Lesions in a Randomized Study
Enrollment Status: Terminated
Publish Date: March 23, 2023
Intervention Type: Device
Study Phase: Not Applicable
XIENCE 28 USA Study
XIENCE 28 USA Study
Enrollment Status: Completed
Publish Date: May 03, 2022
Intervention Type: Drug, Device
Study Phase: Not Applicable
View 7 Less Clinical Trials

2 Total Publications

De Novo Atherosclerotic Renal Artery Stenosis Covered Stent Treatment for Resistant Hypertension (ARTISAN) Results.
De Novo Atherosclerotic Renal Artery Stenosis Covered Stent Treatment for Resistant Hypertension (ARTISAN) Results.
Journal: Journal of the Society for Cardiovascular Angiography & Interventions
Published: July 07, 2024
Similar Doctors
Expertise in
19
conditions
Dr. Stephen P. Luby
Internal Medicine
Expertise in
19
conditions
Dr. Stephen P. Luby
Internal Medicine

Office

473 Via Ortega # Y2, 
Stanford, CA 
 (14.1 miles away)
650-723-4129
Languages Spoken:
English

Stephen Luby is a primary care provider, practicing in Internal Medicine in Stanford, California. Dr. Luby is highly rated in 19 conditions, according to our data. His clinical expertise encompasses Diarrhea, Parainfluenza, Typhoid Fever, and Salmonella Enterocolitis.

Expertise in
20
conditions
Dr. Eri Fukaya
Internal Medicine
Expertise in
20
conditions
Dr. Eri Fukaya
Internal Medicine

Stanford Hospital And Clinics

965 High St, 
Palo Alto, CA 
 (12.5 miles away)
650-723-4000
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Eri Fukaya is a primary care provider, practicing in Internal Medicine in Palo Alto, California. Dr. Fukaya is highly rated in 20 conditions, according to our data. Her clinical expertise encompasses Varicose Veins, Venous Insufficiency, Peripheral Artery Disease, Stasis Dermatitis and Ulcers, and Thrombectomy.

Expertise in
26
conditions
Dr. Monique T. Barakat
Internal Medicine
Expertise in
26
conditions
Dr. Monique T. Barakat
Internal Medicine
Before you request

Stanford Hospital And Clinics

300 Pasteur Dr, 
Stanford, CA 
 (13.6 miles away)
650-723-6661
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Monique Barakat is a primary care provider, practicing in Internal Medicine in Stanford, California. Dr. Barakat is highly rated in 26 conditions, according to our data. Her clinical expertise encompasses Childhood Pancreatitis, Bile Duct Obstruction, Cholestasis, Endoscopy, and Gallbladder Removal. Dr. Barakat is currently accepting new patients.

Frequently Asked Questions about Dr. Ashit Jain

How do I make an appointment with Dr. Ashit Jain?

You can book an appointment with Dr. Ashit Jain by calling their office at 510-796-0222. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Ashit Jain a top-rated expert for Necrosis?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Ashit Jain is classified as an Distinguished expert for Necrosis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Ashit Jain specialize in?

While Dr. Ashit Jain is a Internal Medicine, they have specific expertise in Necrosis, Heart Attack, and Heart Failure with Preserved Ejection Fraction (HFpEF). MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Internal Medicine.

Does Dr. Ashit Jain participate in research or clinical trials?

Yes. Dr. Ashit Jain has published 2 articles and abstracts on conditions like Necrosis. You can view a list of Dr. Ashit Jain's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Ashit Jain accept my insurance?

Dr. Ashit Jain accepts most major insurance plans, including Aetna and Alignment Health Plan. We recommend calling the office directly at 510-796-0222 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Jain's expertise for a condition
ConditionClose
    View All 50 Advanced Conditions
    View All 139 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile